Jury finds Teva fueled opioid addiction in New York - YouTube
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva, GSK
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva Pharmaceutical Industries – The Forward
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva stock gains as company rules out impact from Israel war | Seeking Alpha
Teva profit plummets, stock slides | Ctech
Why Europe's Drug Shortages May Get Worse
Israel's Teva agrees to pay $126 mln to US hospitals over opioids
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Teva divesting $1 billion in assets to clear Allergan deal
Teva enters billion-dollar settlement in US opioid case — MedWatch
AstraZeneca slumps on report CEO is heading to Teva – New York Daily News
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
What's 'down' with Teva? - Israel News - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")